Research ArticleClinical Studies
A Phase I Study of Concurrent Chemoradiotherapy Using Oral S-1 for Head and Neck Cancer
YASUSHI FUJIMOTO, SATOSHI KATO, YOSHIYUKI ITOH, SHINJI NAGANAWA and TSUTOMU NAKASHIMA
Anticancer Research January 2014, 34 (1) 209-213;
YASUSHI FUJIMOTO
1Department of Otorhinolaryngology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan
SATOSHI KATO
1Department of Otorhinolaryngology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan
YOSHIYUKI ITOH
2Department of Radiology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan
SHINJI NAGANAWA
2Department of Radiology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan
TSUTOMU NAKASHIMA
1Department of Otorhinolaryngology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan
In this issue
Anticancer Research
Vol. 34, Issue 1
January 2014
A Phase I Study of Concurrent Chemoradiotherapy Using Oral S-1 for Head and Neck Cancer
YASUSHI FUJIMOTO, SATOSHI KATO, YOSHIYUKI ITOH, SHINJI NAGANAWA, TSUTOMU NAKASHIMA
Anticancer Research Jan 2014, 34 (1) 209-213;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Prognostic Factors in Patients Irradiated for Recurrent Head-and-Neck Cancer
- Radiochemotherapy with Paclitaxel for Recurrent Previously Irradiated Squamous Cell Carcinoma of the Head and Neck
- A Total Radiation Dose of 70 Gy Is Required After Macroscopically Incomplete Resection of Squamous Cell Carcinoma of the Head and Neck
- Importance of Chemotherapy and Radiation Dose After Microscopically Incomplete Resection of Stage III/IV Head and Neck Cancer
- Prognostic Factors After Definitive Radio(Chemo)Therapy of Locally Advanced Head and Neck Cancer
- Critical Evaluation of a Prospective Study of Concurrent Chemoradiotherapy with S-1 for Early Glottic Carcinoma